In short, IGF2BP3 plays an oncogenic role in stabilizing EGFR mRNA in an m6A-dependent manner and further regulates cancer cell proliferation and drug resistance to cetuximab in CRC cells (Fig. 6e). The gene discussed is EGFR; the disease is colorectal carcinoma.